Sign in

You're signed outSign in or to get full access.

JANUS HENDERSON GROUP (JHG)

--

Earnings summaries and quarterly performance for JANUS HENDERSON GROUP.

Recent press releases and 8-K filings for JHG.

Janus Henderson-backed Caldera Therapeutics Launches with $112.5 Million and Doses First Subjects in Phase 1 Trial
JHG
New Projects/Investments
  • Caldera Therapeutics launched with $112.5 million in total capital raised, including a $37.5 million Series A-1 funding round in which Janus Henderson Investors participated.
  • The company announced that the first subjects have been dosed in a Phase 1 trial for its lead program, CLD-423.
  • CLD-423 is a first-in-class bispecific antibody designed to treat inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases.
4 days ago
Janus Henderson to Report Q4 and Full-Year 2025 Results Amidst Pending Acquisition
JHG
Earnings
Guidance Update
M&A
  • Janus Henderson Group (JHG) will announce its fourth quarter and full-year 2025 results pre-market open on Friday, January 30, 2026.
  • The company entered into a definitive merger agreement on December 22, 2025, to be acquired by an investor group led by Trian Fund Management, L.P. and General Catalyst Group Management, LLC.
  • Due to the pending Proposed Transaction, Janus Henderson will not hold conference calls or live webcasts to discuss its financial results and is suspending its financial guidance for full-year 2026.
  • The Proposed Transaction is expected to close in mid-2026, subject to customary closing conditions including regulatory approvals, client consents, and shareholder approval.
5 days ago
Ottimo Pharma Announces FDA Clearance for OTP-01 and Dosing of First Patient
JHG
Product Launch
New Projects/Investments
  • Ottimo Pharma received FDA clearance for its Investigational New Drug (IND) application for OTP-01, a first-in-class, dual-paratopic, anti-PD-1/VEGFR2 antibody.
  • The first patient has been dosed in a broad Phase I/IIA study for OTP-01, which is enrolling patients in the US and Australia.
  • OTP-01 is designed as a next-generation antibody with potent PD-1 inhibition and unique VEGFR2 receptor inhibitory properties, aiming to be a backbone therapy for various solid tumors.
  • All manufacturing of OTP-01 is occurring solely in the US.
Jan 7, 2026, 6:15 PM
Janus Henderson Group plc Announces Merger Agreement
JHG
M&A
Takeover Bid
  • Janus Henderson Group plc (JHG) has entered into an Agreement and Plan of Merger with Jupiter Company Limited and Jupiter Merger Sub Limited, dated December 21, 2025.
  • Under the terms of the merger, each ordinary share of JHG (excluding certain shares) will be converted into the right to receive $49.00 in cash.
  • The transaction is expected to close in mid-2026 and is subject to customary closing conditions, including receipt of applicable regulatory approvals, client consents, and approval by Janus Henderson’s shareholders.
  • The acquisition will be funded in part by investment vehicles managed by Trian and General Catalyst, with additional financing from global investors such as Qatar Investment Authority, Sun Hung Kai & Co. Limited, and MassMutual. Trian and related parties will also roll over their currently held shares.
Dec 22, 2025, 2:19 PM
Janus Henderson Group to be Acquired
JHG
M&A
Takeover Bid
  • Janus Henderson Group plc (NYSE: JHG) has entered into a definitive agreement to be acquired.
  • The acquisition is an all-cash transaction by Trian Fund Management, L.P. and General Catalyst Group Management, LLC.
  • The equity value of the acquisition is approximately $7.4 billion.
  • The announcement was made on December 22, 2025.
Dec 22, 2025, 2:13 PM
Janus Henderson Group to be Acquired by Trian Fund Management and General Catalyst
JHG
M&A
Takeover Bid
New Projects/Investments
  • Janus Henderson Group plc will be acquired by Trian Fund Management and General Catalyst in an all-cash transaction with an equity value of approximately $7.4 billion.
  • Shareholders not already owned or controlled by Trian will receive $49.00 per share in cash, representing an 18% premium to the unaffected closing price on October 24, 2025.
  • The transaction is expected to close in mid-2026 and will involve significant long-term investment in product offerings, client services, technology, and talent, with a focus on applying AI to enhance business operations.
  • Trian Fund Management, which has been a shareholder since 2020 and has Board representation since 2022, currently owns 20.6% of Janus Henderson's outstanding shares.
Dec 22, 2025, 2:13 PM
Janus Henderson Agrees to $7.4 Billion Buyout by Trian-Led Consortium
JHG
M&A
Takeover Bid
New Projects/Investments
  • Janus Henderson has agreed to be acquired by a consortium led by Trian Fund Management and General Catalyst in an all-cash deal valuing the asset manager at approximately $7.4 billion, with shareholders receiving $49 per share.
  • The acquisition price represents a 6.5% premium to the most recent close and an 18% premium to the stock's level before the offer became public in October.
  • The buyer group also includes Qatar Investment Authority and Sun Hung Kai & Co., with Trian, which currently owns about 20.6% of Janus Henderson, having driven a multi-year turnaround.
  • The deal is expected to close in mid-2026 and aims to accelerate investment in people, technology, client services, and product development, with CEO Ali Dibadj continuing to lead the company.
Dec 22, 2025, 2:11 PM
Janus Henderson Group Reports Strong Q3 2025 Results Amidst Acquisition Proposal and CFO Transition
JHG
M&A
Earnings
CFO Change
  • Janus Henderson Group received a non-binding proposal from Trian (a 20.6% shareholder) and General Catalyst to acquire all outstanding ordinary shares not already owned by Trian; a special committee has been appointed to consider the offer.
  • The company reported strong Q3 2025 financial performance, with record Assets Under Management (AUM) of $483.8 billion , a 27% increase year-over-year , driven by the sixth consecutive quarter of positive net flows totaling $7.8 billion. Adjusted diluted EPS increased 20% year-over-year to $1.09.
  • Janus Henderson returned nearly $130 million to shareholders through dividends and share buybacks in Q3 2025. The company is also transitioning its investment management system to Aladdin, which is expected to increase adjusted operating costs by approximately 1% in 2026 and 2027 before delivering efficiencies.
  • CFO Roger Thompson will retire on April 1, 2025, and Suk Rawal, Head of Corporate Development and Strategy, will succeed him.
Oct 30, 2025, 1:00 PM
Janus Henderson Reports Strong Q3 2025 Results and Addresses Takeover Proposal
JHG
Earnings
Takeover Bid
Share Buyback
  • Janus Henderson (JHG) reported strong Q3 2025 results, with Assets Under Management (AUM) reaching a record $483.8 billion, a 27% increase year-over-year, and achieving its sixth consecutive quarter of positive net flows totaling $7.8 billion. Adjusted diluted EPS was $1.09, up 20% from the prior year, and the adjusted operating margin increased 200 basis points to 36.9%.
  • The company is transitioning its investment management system to Aladdin, anticipating an approximately 1% increase in adjusted operating costs for 2026 and 2027, with expected operational improvements and efficiencies from 2028 onwards.
  • A special committee has been appointed to consider a non-binding proposal from Trian and General Catalyst to acquire outstanding ordinary shares of Janus Henderson not already owned by Trian. In Q3 2025, JHG returned nearly $130 million to shareholders through dividends and share buybacks, including repurchasing 1.5 million shares for approximately $67 million.
Oct 30, 2025, 1:00 PM
Janus Henderson Group Reports Strong Q3 2025 Net Inflows and Financial Performance, Announces CFO Transition
JHG
Earnings
CFO Change
New Projects/Investments
  • Janus Henderson Group reported net inflows of $7.8 billion in Q3 2025, marking its sixth consecutive quarter of positive net flows and the best quarterly result ever, excluding Guardian net inflows.
  • The company achieved strong financial performance in Q3 2025, with adjusted operating income improving 22% quarter-over-quarter and adjusted diluted EPS increasing 20% to $1.09 compared to Q3 2024.
  • JHG continued its capital stewardship, returning nearly $130 million to shareholders through dividends and share buybacks in Q3 2025, including repurchasing 1.5 million shares for approximately $67 million.
  • Strategic initiatives include a partnership with CNO Financial Group to accelerate Victory Park Capital's growth and the successful first close of a $300 million Sharia-compliant fund by the Emerging Markets Private Investment team.
  • CFO Roger Thompson will retire on April 1, 2025, with Suk Rawal appointed as his successor. Additionally, the company is transitioning its investment management system to Aladdin, which is projected to increase adjusted operating costs by approximately 1% in 2026 and 2027 before yielding efficiencies.
Oct 30, 2025, 1:00 PM

Quarterly earnings call transcripts for JANUS HENDERSON GROUP.